Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| ARRY | Array BioPharma Inc. | 0.01% | 46.43 | 8.1% | $738.67m | |
| AMGN | Amgen Inc. | 0.42% | 176.86 | 1.3% | $505.72m | |
| CELG | Celgene Corporation | 0.10% | 91.85 | 1.3% | $444.63m | |
| GILD | Gilead Sciences, Inc. | -1.69% | 66.92 | 0.9% | $404.52m | |
| BIIB | Biogen Inc. | -0.31% | 232.89 | 1.3% | $386.46m | |
| ILMN | Illumina, Inc. | 0.37% | 303.42 | 3.5% | $337.03m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.01% | 298.17 | 2.6% | $278.13m | |
| SRPT | Sarepta Therapeutics, Inc. | -2.11% | 153.60 | 14.7% | $204.46m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.63% | 123.82 | 2.0% | $199.41m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 0.17% | 176.67 | 1.9% | $187.80m | |
| EXAS | Exact Sciences Corporation | -0.87% | 115.18 | 24.1% | $139.27m | |
| A | Agilent Technologies, Inc. | -0.84% | 69.96 | 1.6% | $134.13m | |
| INCY | Incyte Corporation | -1.49% | 80.18 | 2.5% | $114.37m | |
| BLUE | Bluebird Bio, Inc. | -1.27% | 134.03 | 14.3% | $97.95m | |
| BMRN | BioMarin Pharmaceutical Inc. | -2.14% | 82.19 | 4.3% | $87.44m |
Company Profile
Cellectar BioSciences, Inc. engages in the development of phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. Its portfolio includes CLR 131, which seeks to treat relapse or refractory multiple myeloma; CLR 125, which intends to treat micro metastatic disease; CLR 124 which could detects tumors and metastases in a broad range of cancers; and CLR 1502, a cancer-targeting near-infrared-fluorophore optical imaging PDC for intraoperative tumor and tumor margin illumination. The company was founded in June,1996 and is headquartered in Florham Park, NJ.